A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Crossover Dose Escalation Study To Investigate The Safety, Toleration And Pharmacokinetics Of Pf-06273340 In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Jul 2012
At a glance
- Drugs PF 6273340 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 03 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jun 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 May 2012 New trial record